R Coleman Lindsley

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 33

Top Venues

Blood advances

Blood

Leukemia

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Harvard Medical School

Washington University in Saint Louis (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Harvard Medical School Jan 01 2018

United States

Assistant Professor

Dana Farber Cancer Institute Jan 01 2018

United States

Assistant Professor :: Department of Medical Oncology

Education History

Washington University in Saint Louis

United States

PHD :: Immunology

Publications

Jan Philipp Bewersdorf, Shai Shimony, Rory Michael Shallis, Yiwen Liu, Guillaume Berton, Eva Johanna Schaefer, Amer M Zeidan, Aaron D Goldberg, Eytan M Stein, Guido Marcucci, Rebecca Bystrom, R Coleman Lindsley, Evan C Chen, Jorge Miguel Ramos Perez, Anthony S Stein, Vinod A Pullarkat, Ibrahim Aldoss, Daniel J DeAngelo, Donna S Neuberg, Richard M Stone, Sylvain Garciaz, Brian J Ball, Maximilian Stahl
Intensive Induction Chemotherapy versus Hypomethylating Agents in Combination with Venetoclax in NPM1-mutant AML. Blood advances (2024)
Jacqueline S Garcia, Haesook T Kim, H Moses Murdock, Michela Ansuinelli, Jennifer Brock, Corey S Cutler, Mahasweta Gooptu, Vincent T Ho, John Koreth, Sarah Nikiforow, Rizwan Romee, Roman Shapiro, Daniel J DeAngelo, Richard M Stone, Denbaa Bat-Erdene, Jeremy Adam Ryan, Manuel E Contreras, Geoffrey G Fell, Anthony Letai, Jerome Ritz, R Coleman Lindsley, Robert J Soiffer, Joseph H Antin
Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML. Blood advances 8 (4) (2024)
Rathnam K Venkat, Robert A Redd, Amyah C Harris, Martin J Aryee, Anna E Marneth, Baransel Kamaz, Chulwoo J Kim, Mohammed Wazir, Lachelle Dawn Weeks, Maximilian Stahl, Daniel J DeAngelo, R Coleman Lindsley, Marlise R Luskin, Gabriela S Hobbs, Joan How
Risk of Bleeding in Essential Thrombocythemia Patients with Extreme Thrombocytosis. Blood advances (2024)
Jacqueline S Garcia, Haesook T Kim, H Moses Murdock, Michela Ansuinelli, Jennifer Brock, Corey S Cutler, Mahasweta Gooptu, Vincent T Ho, John Koreth, Sarah Nikiforow, Rizwan Romee, Roman Shapiro, Daniel J DeAngelo, Richard M Stone, Denbaa Bat-Erdene, Jeremy Adam Ryan, Manuel E Contreras, Geoffrey G Fell, Anthony Letai, Jerome Ritz, R Coleman Lindsley, Robert J Soiffer, Joseph H Antin
Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML. Blood advances 8 (4) (2024)
Shai Shimony, Jacqueline S Garcia, Julia Keating, Evan C Chen, Marlise R Luskin, Maximilian Stahl, Donna S Neuberg, Daniel J DeAngelo, Richard M Stone, R Coleman Lindsley
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients. Leukemia 38 (7) (2024)
Shai Shimony, Jacqueline S Garcia, Julia Keating, Evan C Chen, Marlise R Luskin, Maximilian Stahl, Donna S Neuberg, Daniel J DeAngelo, Richard M Stone, R Coleman Lindsley
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients. Leukemia 38 (7) (2024)
Shai Shimony, Jacqueline S Garcia, Julia Keating, Evan C Chen, Marlise R Luskin, Maximilian Stahl, Donna S Neuberg, Daniel J DeAngelo, Richard M Stone, R Coleman Lindsley
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients. Leukemia 38 (7) (2024)
Shai Shimony, Jacqueline S Garcia, Julia Keating, Evan C Chen, Marlise R Luskin, Maximilian Stahl, Donna S Neuberg, Daniel J DeAngelo, Richard M Stone, R Coleman Lindsley
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients. Leukemia 38 (7) (2024)
Rahul S Vedula, Hannah Q Karp, Jeremy Koob, Felicia Lim, Jacqueline S Garcia, Eric S Winer, Marlise R Luskin, Gabriel Ghiaur, Annette S Kim, Lan W Beppu, Olga Sala-Torra, Jerald P Radich, Jonathan Samuel Gootenberg, Omar Abudayyeh, Feng Zhang, R Coleman Lindsley
CRISPR-based rapid molecular diagnostic tests for fusion-driven leukemias. Blood (2024)
Jacqueline S Garcia, Haesook T Kim, H Moses Murdock, Michela Ansuinelli, Jennifer Brock, Corey S Cutler, Mahasweta Gooptu, Vincent T Ho, John Koreth, Sarah Nikiforow, Rizwan Romee, Roman Shapiro, Daniel J DeAngelo, Richard M Stone, Denbaa Bat-Erdene, Jeremy Adam Ryan, Manuel E Contreras, Geoffrey G Fell, Anthony Letai, Jerome Ritz, R Coleman Lindsley, Robert J Soiffer, Joseph H Antin
Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML. Blood advances 8 (4) (2024)
Shai Shimony, Jacqueline S Garcia, Julia Keating, Evan C Chen, Marlise R Luskin, Maximilian Stahl, Donna S Neuberg, Daniel J DeAngelo, Richard M Stone, R Coleman Lindsley
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients. Leukemia (2024)
Jacqueline S Garcia, Haesook T Kim, H Moses Murdock, Michela Ansuinelli, Jennifer Brock, Corey S Cutler, Mahasweta Gooptu, Vincent T Ho, John Koreth, Sarah Nikiforow, Rizwan Romee, Roman M Shapiro, Daniel J DeAngelo, Richard M Stone, Denbaa Bat-Erdene, Jeremy Adam Ryan, Manuel E Contreras, Geoffrey G Fell, Anthony Letai, Jerome Ritz, R Coleman Lindsley, Robert J Soiffer, Joseph H Antin
Prophylactic maintenance with venetoclax/azacitidine after reduced intensity conditioning allo-transplant for high risk MDS and AML. Blood advances (2024)
Jacqueline S Garcia, Haesook T Kim, H Moses Murdock, Michela Ansuinelli, Jennifer Brock, Corey S Cutler, Mahasweta Gooptu, Vincent T Ho, John Koreth, Sarah Nikiforow, Rizwan Romee, Roman Shapiro, Daniel J DeAngelo, Richard M Stone, Denbaa Bat-Erdene, Jeremy Adam Ryan, Manuel E Contreras, Geoffrey G Fell, Anthony Letai, Jerome Ritz, R Coleman Lindsley, Robert J Soiffer, Joseph H Antin
Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML. Blood advances 8 (4) (2024)
Shai Shimony, Jacqueline S Garcia, Julia Keating, Evan C Chen, Marlise R Luskin, Maximilian Stahl, Donna S Neuberg, Daniel J DeAngelo, Richard M Stone, R Coleman Lindsley
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients. Leukemia 38 (7) (2024)
Shai Shimony, Geoffrey G Fell, Evan C Chen, Harrison K Tsai, Martha Wadleigh, Eric S Winer, Jacqueline S Garcia, Marlise R Luskin, Maximilian Stahl, Donna S Neuberg, Daniel J DeAngelo, R Coleman Lindsley, Richard M Stone
FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients age ≥60 years. Blood advances (2023)
Peter Grant Miller, Adam S Sperling, Christina Mayerhofer, Marie McConkey, Jana Maria Ellegast, Carmen Da Silva, Drew Nathaniel Cohen, Chuqi Wang, Azeem Sharda, Ni Yan, Subha Saha, Cameron Schluter, Ilexa Ashley Schechter, Mikołaj Słabicki, Brittany Sandoval, Josephine Kahn, Steffen Boettcher, Christopher J Gibson, David T Scadden, Kimberly Stegmaier, Shruti Bhatt, R Coleman Lindsley, Benjamin L Ebert
PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy. Blood (2023)
Amy E DeZern, Johannes B Goll, R Coleman Lindsley, Rafael Bejar, Steffanie H Wilson, Donnie Hebert, H Joachim Deeg, Ling Zhang, Steven D Gore, Tareq Al Baghdadi, Jaroslaw P Maciejewski, Jane Jijun Liu, Eric Padron, Rami S Komrokji, Wael Saber, Gregory A Abel, Steven H Kroft, Alexandra M Harrington, Somnath Datta, Harrison H Vaughn Reed, Robert S Fulton, Nancy L DiFronzo, Nancy Gillis, Mikkael A Sekeres, Matthew J Walter
Utility of Targeted Gene Sequencing to Differentiate Myeloid Malignancies from other Cytopenic Conditions. Blood advances (2023)
Jurjen Versluis, Wael Saber, Harrison K Tsai, Christopher J Gibson, Laura W Dillon, Asmita Mishra, Joseph P McGuirk, Richard T Maziarz, Peter Westervelt, Pranay S Hegde, Devdeep Mukherjee, Michael J Martens, Brent R Logan, Mary M Horowitz, Christopher S Hourigan, Ryotaro Nakamura, Corey S Cutler, R Coleman Lindsley, null null
Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Ali AlJabban, Hyun-Il Paik, Jon C Aster, Nancy Berliner, Jennifer Brouillard, Jennifer R Brown, Kathleen H Burns, Jorge J Castillo, James Card, Paola Dal Cin, Daniel J DeAngelo, David M Dorfman, Benjamin L Ebert, Jacqueline S Garcia, Caron A Jacobson, Hakim Lakhani, Jacob P Laubach, Azra H Ligon, Neal I Lindeman, R Coleman Lindsley, Scott B Lovitch, Marlise R Luskin, Elizabeth A Morgan, Andrew Nowak, Athena Petrides, Geraldine S Pinkus, Olga Pozdnyakova, David P Steensma, Richard M Stone, Olga K Weinberg, Eric S Winer, Annette S Kim
Optimization of Advanced Molecular Genetic Testing Utilization in Hematopathology: A Goldilocks Approach to Bone Marrow Testing. JCO oncology practice (2023)
Jurjen Versluis, Manu Pandey, Yael Flamand, J Erika Haydu, Roger Belizaire, Mark G Faber, Rahul S Vedula, Anne Charles, Kevin M Copson, Shai Shimony, Alon Rozental, Pavan K Bendapudi, Ofir Wolach, Elizabeth A Griffiths, James E Thompson, Richard M Stone, Daniel J DeAngelo, Donna Neuberg, Marlise R Luskin, Eunice S Wang, R Coleman Lindsley
Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy. Blood advances 6 (9) (2022)
Mathieu Gigoux, Morten Orebo Holmström, Roberta Zappasodi, Joseph J Park, Stephane Pourpe, Cansu Cimen Bozkus, Levi Mark Mangarin, David Redmond, Svena Verma, Sara Schad, Mariam M George, Divya Venkatesh, Arnab Ghosh, David Hoyos, Zaki Molvi, Baransel Kamaz, Anna E Marneth, William Duke, Matthew Joseph Leventhal, Max Jan, Vincent T Ho, Gabriela S Hobbs, Trine Alma Knudsen, Vibe Skov, Lasse Kjær, Thomas Stauffer Larsen, Dennis Lund Hansen, R Coleman Lindsley, Hans Carl Carl Hasselbalch, Jacob H Grauslund, Thomas L Lisle, Özcan Met, Patrick Wilkinson, Benjamin Greenbaum, Manuel A Sepulveda, Timothy A Chan, Raajit Rampal, Mads Hald Andersen, Omar Abdel-Wahab, Nina Bhardwaj, Jedd D Wolchok, Ann Mullally, Taha Merghoub
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine. Science translational medicine 14 (649) (2022)
Harrison K Tsai, Christopher J Gibson, H Moses Murdock, Phani Davineni, Marian H Harris, Eunice S Wang, Lukasz P Gondek, Annette S Kim, Valentina Nardi, R Coleman Lindsley
Allelic complexity of KMT2A partial tandem duplications in acute myeloid leukemia and myelodysplastic syndromes. Blood advances 6 (14) (2022)
Simone K Feurstein, Amy M Trottier, Noel Estrada-Merly, Matthew J Pozsgai, Kelsey E McNeely, Michael W Drazer, Brian Ruhle, Katharine Sadera, Ashwin L Koppayi, Bart L Scott, Betul Oran, Taiga Nishihori, Vaibhav Agrawal, Ayman Saad, R Coleman Lindsley, Ryotaro Nakamura, Soyoung Kim, Zhen-Huan Hu, Ronald M Sobecks, Stephen R Spellman, Wael Saber, Lucy A Godley
Germline predisposition variants occur in myelodysplastic syndrome patients of all ages. Blood (2022)
Sisi Chen, Rahul S Vedula, Antonio Cuevas-Navarro, Bin Lu, Simon J Hogg, Eric Wang, Salima Benbarche, Katherine Knorr, Won Jun Kim, Robert F Stanley, Hana Cho, Caroline Erickson, Michael Singer, Dan Cui, Steven Tittley, Benjamin H Durham, Tatiana S Pavletich, Elise Fiala, Michael F Walsh, Daichi Inoue, Sebastien Monette, Justin Taylor, Neal X Rosen, Frank McCormick, R Coleman Lindsley, Hatice Ulku Osmanbeyoglu, Omar Abdel-Wahab
Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation. Cancer discovery 12 (10) (2022)
H Moses Murdock, Haesook T Kim, Nathan Denlinger, Pankit Vachhani, Bryan C Hambley, Bryan S Manning, Shannon Gier, Christina Cho, Harrison K Tsai, Shannon McCurdy, Vincent T Ho, John Koreth, Robert J Soiffer, Jerome Ritz, Miguel-Ángel Perales, Sumithira Vasu, Miguel-Angel Perales, Eunice S Wang, Lukasz P Gondek, Steven Devine, Edwin P Alyea, R Coleman Lindsley, Christopher J Gibson
Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML. Blood 139 (24) (2022)
Jacqueline S Garcia, Haesook T Kim, H Moses Murdock, Corey S Cutler, Jennifer Brock, Mahasweta Gooptu, Vincent T Ho, John Koreth, Sarah Nikiforow, Rizwan Romee, Roman M Shapiro, Fiona Loschi, Jeremy Adam Ryan, Geoffrey Fell, Hannah Q Karp, Jennifer A Woyach, Annette S Kim, Danielle Sinead Potter, Thelma Mashaka, Richard M Stone, Daniel J DeAngelo, Anthony Letai, R Coleman Lindsley, Robert J Soiffer, Joseph H Antin
Adding venetoclax to fludarabine/busulfan RIC transplant for high risk MDS and AML is feasible, safe, and active. Blood advances (2021)
Alyssa L Kennedy, Kasiani C Myers, James Bowman, Christopher J Gibson, Nicholas D Camarda, Elissa Furutani, Gwen M Muscato, Robert H Klein, Kaitlyn Ballotti, Shanshan Liu, Chad E Harris, Ashley Galvin, Maggie Malsch, David Dale, John M Gansner, Taizo A Nakano, Alison Bertuch, Adrianna Vlachos, Jeffrey M Lipton, Paul Castillo, James Connelly, Jane Churpek, John R Edwards, Nobuko Hijiya, Richard H Ho, Inga Hofmann, James N Huang, Siobán Keel, Adam Lamble, Bonnie W Lau, Maxim Norkin, Elliot Stieglitz, Wendy Stock, Kelly Walkovich, Steffen Boettcher, Christian Brendel, Mark Daniel Fleming, Stella M Davies, Edie A Weller, Christopher Bahl, Scott L Carter, Akiko Shimamura, R Coleman Lindsley
Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome. Nature communications 12 (1) (2021)
Christopher R Reilly, Mikko Myllymäki, Robert A Redd, Shilpa Padmanaban, Druha Karunakaran, Valerie Tesmer, Frederick D Tsai, Christopher J Gibson, Huma Q Rana, Liang Zhong, Wael Saber, Stephen R Spellman, Zhen-Huan Hu, Esther H Orr, Maxine M Chen, Immaculata De Vivo, Daniel J DeAngelo, Corey Cutler, Joseph H Antin, Donna Neuberg, Judy E Garber, Jayakrishnan Nandakumar, Suneet Agarwal, R Coleman Lindsley
The clinical and functional effects of TERT variants in myelodysplastic syndrome. Blood 138 (10) (2021)
Thomas Pincez, Simon S K Lee, Yann Ilboudo, Michael H Preuss, Anne-Laure Pham-Hung D'Alexandry D'Orengiani, Pablo Bartolucci, Frédéric Galactéros, Philippe Joly, Daniel E Bauer, Ruth J F Loos, R Coleman Lindsley, Guillaume Lettre
Clonal hematopoiesis in sickle cell disease. Blood 138 (21) (2021)
Trine Alma Knudsen, Vibe Skov, Kristen E Stevenson, Lillian Werner, William Duke, Charles Laurore, Christopher James Gibson, Anwesha Nag, Aaron R Thorner, Bruce Wollison, Dennis Lund Hansen, Christina Ellervik, Daniel El Fassi, Karin de Stricker, Lukas Frans Ocias, Mette Brabrand, Ole Weis Bjerrum, Ulrik Overgaard, Mikael Frederiksen, Thomas Kristensen, Torben Kruse, Mads Thomassen, Torben Mourits-Andersen, Marianne Tang Severinsen, Jesper Stentoft, Jørn Starklint, Donna Neuberg, Lasse Kjaer, Thomas S Larsen, Hans Carl Carl Hasselbalch, R Coleman Lindsley, Ann Mullally
Genomic Profiling of a Randomized Trial of Interferon-α versus Hydroxyurea in MPN Reveals Mutation-Specific Responses. Blood advances (2021)
Christopher J Gibson, Haesook T Kim, Lin Zhao, H Moses Murdock, Bryan C Hambley, Alana F Ogata, Rafael Madero-Marroquin, Shiyu Wang, Lisa Green, Mark Fleharty, Tyler J Dougan, Chi-An Cheng, Brendan Blumenstiel, Carrie Cibulskis, Junko Tsuji, Madeleine Duran, Christopher D Gocke, Joseph H Antin, Sarah Nikiforow, Amy E DeZern, Yi-Bin Chen, Vincent T Ho, Richard J Jones, Niall J Lennon, David R Walt, Jerome Ritz, Robert J Soiffer, Lukasz P Gondek, R Coleman Lindsley
Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Christopher J Gibson, James A Kennedy, Sarah Nikiforow, Frank C Kuo, Edwin P Alyea, Vincent Ho, Jerome Ritz, Robert Soiffer, Joseph H Antin, R Coleman Lindsley
Donor-engrafted CHIP is common among stem cell transplant recipients with unexplained cytopenias. Blood 130 (1) (2017)
Frank C Kuo, Brenton G Mar, R Coleman Lindsley, Neal I Lindeman
The relative utilities of genome-wide, gene panel, and individual gene sequencing in clinical practice. Blood 130 (4) (2017)

R Coleman Lindsley.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

R Coleman Lindsley